Aptevo Therapeutics Inc (APVO)
0.7025
+0.02
(+3.31%)
USD |
NASDAQ |
Apr 26, 16:00
0.7025
0.00 (0.00%)
After-Hours: 17:39
Aptevo Therapeutics Total Assets (Quarterly): 24.84M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.84M |
| September 30, 2023 | 27.13M |
| June 30, 2023 | 28.91M |
| March 31, 2023 | 34.97M |
| December 31, 2022 | 34.22M |
| September 30, 2022 | 31.70M |
| June 30, 2022 | 38.80M |
| March 31, 2022 | 45.18M |
| December 31, 2021 | 56.60M |
| September 30, 2021 | 64.00M |
| June 30, 2021 | 71.47M |
| March 31, 2021 | 68.75M |
| December 31, 2020 | 53.55M |
| September 30, 2020 | 37.42M |
| June 30, 2020 | 18.51M |
| March 31, 2020 | 25.24M |
| December 31, 2019 | 53.41M |
| Date | Value |
|---|---|
| September 30, 2019 | 60.56M |
| June 30, 2019 | 66.13M |
| March 31, 2019 | 80.84M |
| December 31, 2018 | 67.49M |
| September 30, 2018 | 78.93M |
| June 30, 2018 | 90.00M |
| March 31, 2018 | 100.21M |
| December 31, 2017 | 117.01M |
| September 30, 2017 | 131.02M |
| June 30, 2017 | 86.89M |
| March 31, 2017 | 97.79M |
| December 31, 2016 | 91.86M |
| September 30, 2016 | 100.62M |
| June 30, 2016 | 118.16M |
| March 31, 2016 | 141.59M |
| December 31, 2015 | 127.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.51M
Minimum
Jun 2020
71.47M
Maximum
Jun 2021
44.28M
Average
38.80M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Heron Therapeutics Inc | 222.51M |
| Creative Medical Technology Holdings Inc | 10.72M |
| BioSig Technologies Inc | 1.798M |
| Adial Pharmaceuticals Inc | 4.737M |
| IN8bio Inc | 33.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.62M |
| Shareholders Equity (Quarterly) | 12.22M |